Trump scraps Biden’s plan to cover Wegovy and Zepbound through Medicare

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government’s Medicare program.

The Centers for Medicare and Medicaid Services said late Friday that it would not cover the medications under Medicare’s Part D prescription drug coverage. Medicare covers health care expenses mainly for people age 65 and older.

Trump’s predecessor, Joe Biden, proposed a rule in late November after Trump won reelection that would...